Morphogenesis, a Tampa clinical-stage company developing novel therapies to treat cancer, has closed a $22.2 million round. “This gives us the most runway we’ve ever had,”...
The new CEO at Morphogenesis, a Tampa clinical-stage company that’s developing novel therapies to treat cancer, is determined to take the company public within two years. ...
Morphogenesis, a Tampa biotechnology company developing treatments for cancer, has raised $2.7 million in equity capital. The funding came from 24 investors and is part of...
Venture funding for Tampa-St. Pete companies got off to a strong start in the fourth quarter of 2019, when CoLabs, a software firm in Tampa, raised...
